Infant Bacterial Therapeutics AB (publ)
SSE:IBT-B.ST
93.4 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||
Current Assets: | ||||||||||||
Cash & Cash Equivalents
| 329.064 | 335.84 | 386.752 | 423.438 | 495.188 | 542.17 | 158.274 | 93.786 | 44.411 | 1.054 | 0.901 | 0.048 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 329.064 | 335.84 | 386.752 | 423.438 | 495.188 | 542.17 | 158.274 | 93.786 | 44.411 | 1.054 | 0.901 | 0.048 |
Net Receivables
| 0 | 1.778 | 1.202 | 1.955 | 0.713 | 7.114 | 2.102 | 0.761 | 20.955 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | -7.114 | -2.102 | 0 | -20.955 | 0 | 0 | 0 |
Other Current Assets
| 12.499 | 1.413 | 9.14 | 12.725 | 9.356 | 7.369 | 2.102 | 0.909 | 21.907 | 7.408 | 0.388 | 0 |
Total Current Assets
| 341.563 | 339.031 | 397.094 | 438.118 | 505.257 | 549.539 | 160.376 | 94.695 | 66.318 | 8.462 | 1.289 | 0.048 |
Non-Current Assets: | ||||||||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 9.702 | 10.518 | 11.334 | 12.15 | 12.966 | 13.782 | 14.598 | 15.414 | 16.225 | 6.075 | 0 | 0 |
Goodwill and Intangible Assets
| 9.702 | 10.518 | 11.334 | 12.15 | 12.966 | 13.782 | 14.598 | 15.414 | 16.225 | 6.075 | 0 | 0 |
Long Term Investments
| 0.07 | 0.07 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Assets
| 9.772 | 10.588 | 11.384 | 12.2 | 13.016 | 13.832 | 14.648 | 15.414 | 16.225 | 6.075 | 0 | 0 |
Total Assets
| 351.334 | 349.619 | 408.478 | 450.318 | 518.273 | 563.371 | 175.024 | 110.109 | 82.543 | 14.537 | 1.289 | 0.048 |
Liabilities & Equity: | ||||||||||||
Current Liabilities: | ||||||||||||
Account Payables
| 30.067 | 8.746 | 4.797 | 1.232 | 0.943 | 3.507 | 0.506 | 1.116 | 0.518 | 0.492 | 0.062 | 0 |
Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0.613 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 16.113 | 0.421 | 3.63 | 7.7 | 5.99 | -0.973 | 5.641 | 2.651 | 6.698 | 2.522 | 0.116 | 0 |
Total Current Liabilities
| 46.18 | 17.913 | 13.224 | 10.164 | 7.876 | 6.654 | 6.653 | 4.883 | 7.734 | 3.506 | 0.241 | 0 |
Non-Current Liabilities: | ||||||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 8.746 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 0 | 8.746 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities
| 46.18 | 17.913 | 13.224 | 10.164 | 7.876 | 6.654 | 6.653 | 4.883 | 7.734 | 3.506 | 0.241 | 0 |
Equity: | ||||||||||||
Preferred Stock
| 0 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 3.672 | 3.06 | 3.06 | 3.06 | 3.06 | 3.06 | 1.8 | 1.5 | 0.5 | 0.05 | 0.05 | 0.05 |
Retained Earnings
| -465.348 | -342.28 | -276.828 | -231.837 | -159.83 | -113.51 | -72.903 | -36.747 | 21.959 | 10.981 | -0.002 | -0.002 |
Accumulated Other Comprehensive Income/Loss
| 0.001 | -0.001 | -0 | -0 | -0 | 0 | 0 | -0 | 52.85 | 0 | 1 | 0 |
Other Total Stockholders Equity
| 766.829 | 670.926 | 669.022 | 668.931 | 667.167 | 667.167 | 239.474 | 140.473 | -0.5 | 0 | 0 | 0 |
Total Shareholders Equity
| 305.154 | 331.706 | 395.254 | 440.154 | 510.397 | 556.717 | 168.371 | 105.226 | 74.809 | 11.031 | 1.048 | 0.048 |
Total Equity
| 305.154 | 331.706 | 395.254 | 440.154 | 510.397 | 556.717 | 168.371 | 105.226 | 74.809 | 11.031 | 1.048 | 0.048 |
Total Liabilities & Shareholders Equity
| 351.334 | 349.619 | 408.478 | 450.318 | 518.273 | 563.371 | 175.024 | 110.109 | 82.543 | 14.537 | 1.289 | 0 |